Industry Reports
Imprimis Pharmaceuticals acquires license to patented formulation for dry eye disease
Imprimis Pharmaceuticals Inc , an ophthalmology-focused pharmaceutical company, announced that it has entered into an licensing agreement for the exclusive worldwide rights to Klarity, an innovative and patented ophthalmic topical solution and gel technology for patients with dry eye...
Industry Reports
Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus’ on-demand topical cream for erectile dysfunction
Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus’ Vitaros. Vitaros is an on-demand topical cream indicated for the treatment of patients with erectile...
Industry Reports
Thermo Fisher Scientific Acquires Core Informatics, Provider of Leading Cloud-Based Scientific Data Platforms
Thermo Fisher Scientific Inc, the world leader in serving science announced that it has acquired Core Informatics, which provides a leading cloud-based platform supporting scientific data management. Core’s offerings will significantly enhance Thermo Fisher’s existing informatics...
Industry Reports
ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials
ICON plc a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a project by the US FDA to validate three PRO instruments that will...
Industry Reports
Takeda Completes Acquisition of ARIAD Pharmaceuticals Inc
Takeda Pharmaceutical Company Limited announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc for $24.00 per share in cash. “We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals. The addition of ARIAD’s...
Industry Reports
Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc
Thermo Fisher Scientific Inc, the world leader in serving science completed its previously announced acquisition of Finesse Solutions, Inc., a leader in the development of scalable control automation systems and software for bioproduction. The business will...
Industry Reports
Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical
Aurobindo Pharma Limited is pleased to announce the acquisition of four cell culture derived biosimilar products from TL Biopharmaceutical AG. As part of this agreement, TL will supply all the developmental data for four molecules and Aurobindo and/or its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read